Todd S. Thomson - 05 Jan 2026 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ACTU
Reported as of: 05 Jan 2026
Net transaction value: -$1,624,000
SEC form: 4
Accepted by SEC: 07 Jan 2026, 12:45:49 UTC
Prior SEC filing: 23 May 2025
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: TODD THOMSON /s/ Todd Thomson

Key filing fact

Todd S. Thomson filed Form 4 for ACTUATE THERAPEUTICS, INC. (ACTU) on 07 Jan 2026.

Key facts

This page summarizes Todd S. Thomson's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jan 2026, 12:45.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: -$1,624,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001225707 Primary reporting owner

THOMSON TODD S

Relationship: Director, 10%+ Owner
Address: 9440 SANTA MONICA BLVD, SUITE 710, BEVERLY HILLS
Signature: TODD THOMSON /s/ Todd Thomson
Signature date: 07 Jan 2026

CIK 0001696711

Kairos Venture Partners II, L.P.

Relationship: Director, 10%+ Owner
Address: 9440 SOUTH SANTA MONICA BLVD., #710, BEVERLY HILLS
Signature: KAIROS VENTURE PARTNERS II, L.P. /s/ James T. Demetriades, Authorized Signatory
Signature date: 07 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACTU transaction

Common Stock

Sale

Transaction value: $1,624,000
Shares: -280,000
Change %: -24%
Price: $5.80
Shares after: 904,795
Date: 05 Jan 2026
Ownership: By Kairos Venture Partners II, L.P.
Footnotes: F1, F2

ACTU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 873,033
Date: 05 Jan 2026
Ownership: By Kairos Venture Opportunities I, L.P.
Footnotes: F1, F2

ACTU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 321,781
Date: 05 Jan 2026
Ownership: By Kairos SPV Fund, LLC
Footnotes: F1, F2

ACTU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 254,735
Date: 05 Jan 2026
Ownership: By Kairos-Actuate SPV, L.P.
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The securities of Actuate Therapeutics, Inc. ("Actuate") that are reported herein are held directly by Kairos-Actuate SPV, L.P., Kairos Venture Partners II, L.P., Kairos Venture Opportunities I, L.P., and Kairos SPV Fund, LLC (collectively, the "Kairos Funds"). The Kairos Funds are managed and controlled by Kairos Venture Investments, LLC ("KVI"), subject to the Limited Partnership Agreements in place for each Kairos Fund. Todd Thomson serves as Chief Financial Officer/Chief Operating Officer of KVI and is a director on the board of directors of Actuate. James Demetriades is the Chief Executive Officer of KVI.

Footnote F2

Each of KVI, Mr. Thomson and Mr. Demetriades may be deemed to indirectly beneficially own the securities of Actuate held directly by the Kairos Funds. Each of KVI, Mr. Thomson and Mr. Demetriades disclaims beneficial ownership of the securities of Actuate held directly by the Kairos Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of KVI, Mr. Thomson or Mr. Demetriades is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

SEC remarks

Todd Thomson serves as CFO/COO of Kairos Venture Investments, LLC and is a director on the board of directors of Actuate Therapeutics, Inc. ("Actuate"). Due to their relationship with Todd Thomson, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the Reporting Persons other than Todd Thomson are deemed to be directors by deputization of Actuate.